Xiangsheng Yang1, Tiannan Wang2, Xi Lin1, Xiaojing Yue1, Qiongling Wang2, Guoliang Wang2, Qin Fu3, Xun Ai4, David Y Chiang2, Christina Y Miyake5, Xander H T Wehrens2, Jiang Chang1. 1. Texas A&M University Health Science Center, Institute of Biosciences and Technology, Houston, TX 77030. 2. Department of Molecular Physiology & Biophysics, and Medicine (Cardiology), Baylor College of Medicine, Houston, TX 77030. 3. Department of Pharmacology, University of California at Davis, CA 95616. 4. Department of Cell and Molecular Physiology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153. 5. Texas Children's Hospital, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030.
Abstract
RATIONALE: Rnd3, a small Rho GTPase, is involved in the regulation of cell actin cytoskeleton dynamics, cell migration, and proliferation. The biological function of Rnd3 in the heart remains unexplored. OBJECTIVE: To define the functional role of the Rnd3 gene in the animal heart and investigate the associated molecular mechanism. METHODS AND RESULTS: By loss-of-function approaches, we discovered that Rnd3 is involved in calcium regulation in cardiomyocytes. Rnd3-null mice died at the embryonic stage with fetal arrhythmias. The deletion of Rnd3 resulted in severe Ca(2+) leakage through destabilized ryanodine receptor type 2 Ca(2+) release channels. We further found that downregulation of Rnd3 attenuated β2-adrenergic receptor lysosomal targeting and ubiquitination, which in turn resulted in the elevation of β2-adrenergic receptor protein levels leading to the hyperactivation of protein kinase A (PKA) signaling. The PKA activation destabilized ryanodine receptor type 2 channels. This irregular spontaneous Ca(2+) release can be curtailed by PKA inhibitor treatment. Increases in the PKA activity along with elevated cAMP levels were detected in Rnd3-null embryos, in neonatal rat cardiomyocytes, and noncardiac cell lines with Rnd3 knockdown, suggesting a general mechanism for Rnd3-mediated PKA signaling activation. β2-Adrenergic receptor blocker treatment reduced arrhythmia and improved cardiac function. CONCLUSIONS: Rnd3 is a novel factor involved in intracellular Ca(2+) homeostasis regulation in the heart. Deficiency of the protein induces ryanodine receptor type 2 dysfunction by a mechanism that attenuates Rnd3-mediated β2-adrenergic receptor ubiquitination, which leads to the activation of PKA signaling. Increased PKA signaling in turn promotes ryanodine receptor type 2 hyperphosphorylation, which contributes to arrhythmogenesis and heart failure.
RATIONALE: Rnd3, a small Rho GTPase, is involved in the regulation of cell actin cytoskeleton dynamics, cell migration, and proliferation. The biological function of Rnd3 in the heart remains unexplored. OBJECTIVE: To define the functional role of the Rnd3 gene in the animal heart and investigate the associated molecular mechanism. METHODS AND RESULTS: By loss-of-function approaches, we discovered that Rnd3 is involved in calcium regulation in cardiomyocytes. Rnd3-null mice died at the embryonic stage with fetal arrhythmias. The deletion of Rnd3 resulted in severe Ca(2+) leakage through destabilized ryanodine receptor type 2Ca(2+) release channels. We further found that downregulation of Rnd3 attenuated β2-adrenergic receptor lysosomal targeting and ubiquitination, which in turn resulted in the elevation of β2-adrenergic receptor protein levels leading to the hyperactivation of protein kinase A (PKA) signaling. The PKA activation destabilized ryanodine receptor type 2 channels. This irregular spontaneous Ca(2+) release can be curtailed by PKA inhibitor treatment. Increases in the PKA activity along with elevated cAMP levels were detected in Rnd3-null embryos, in neonatal rat cardiomyocytes, and noncardiac cell lines with Rnd3 knockdown, suggesting a general mechanism for Rnd3-mediated PKA signaling activation. β2-Adrenergic receptor blocker treatment reduced arrhythmia and improved cardiac function. CONCLUSIONS:Rnd3 is a novel factor involved in intracellular Ca(2+) homeostasis regulation in the heart. Deficiency of the protein induces ryanodine receptor type 2 dysfunction by a mechanism that attenuates Rnd3-mediated β2-adrenergic receptor ubiquitination, which leads to the activation of PKA signaling. Increased PKA signaling in turn promotes ryanodine receptor type 2 hyperphosphorylation, which contributes to arrhythmogenesis and heart failure.
Authors: Dennis Fiegen; Lars Blumenstein; Patricia Stege; Ingrid R Vetter; Mohammad Reza Ahmadian Journal: FEBS Lett Date: 2002-08-14 Impact factor: 4.124
Authors: C L Antos; N Frey; S O Marx; S Reiken; M Gaburjakova; J A Richardson; A R Marks; E N Olson Journal: Circ Res Date: 2001-11-23 Impact factor: 17.367
Authors: Stephan E Lehnart; Xander H T Wehrens; Päivi J Laitinen; Steven R Reiken; Shi-Xiang Deng; Zhenzhuang Cheng; Donald W Landry; Kimmo Kontula; Heikki Swan; Andrew R Marks Journal: Circulation Date: 2004-06-14 Impact factor: 29.690
Authors: Jiajie Yan; Weiwei Zhao; Justin K Thomson; Xianlong Gao; Dominic M DeMarco; Elena Carrillo; Biyi Chen; Xiaomin Wu; Kenneth S Ginsburg; Mamdouh Bakhos; Donald M Bers; Mark E Anderson; Long-Sheng Song; Michael Fill; Xun Ai Journal: Circ Res Date: 2018-01-19 Impact factor: 17.367
Authors: Jerome W Breslin; Dayle A Daines; Travis M Doggett; Kristine H Kurtz; Flavia M Souza-Smith; Xun E Zhang; Mack H Wu; Sarah Y Yuan Journal: J Am Heart Assoc Date: 2016-04-05 Impact factor: 5.501